REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

20/03/2020 11:45

RNS Number : 0060H
  
Morgan Stanley Capital Services LLC
  
20 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION




 Name of exempt market-maker


 Morgan Stanley Capital Services LLC




 Company dealt in


 ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


 US$0.01 COMMON STOCK




 Date of dealing


 19 MARCH 2020




 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales




 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  50,574


 74.1700 USD


 65.0527 USD




 




 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  17,894


 74.6100 USD


 67.0500 USD




 
 
(b)           Derivatives transactions (other than options transactions)
 




 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 1,600


 67.4291 USD




 CFD


 LONG


 127


 67.6700 USD




 CFD


 LONG


 700


 69.1357 USD




 CFD


 LONG


 6,167


 69.1999 USD




 CFD


 LONG


 100


 70.5571 USD




 CFD


 LONG


 100


 70.5571 USD




 CFD


 LONG


 500


 70.5571 USD




 CFD


 LONG


 14


 71.0600 USD




 CFD


 LONG


 86


 71.0600 USD




 CFD


 LONG


 13


 71.4554 USD




 CFD


 LONG


 85


 72.5100 USD




 CFD


 LONG


 2,800


 73.2148 USD




 CFD


 LONG


 61


 73.6980 USD




 CFD


 SHORT


 120


 67.4200 USD




 CFD


 SHORT


 34


 68.1500 USD




 CFD


 SHORT


 15


 68.2193 USD




 CFD


 SHORT


 50


 68.2700 USD




 CFD


 SHORT


 20


 69.1610 USD




 CFD


 SHORT


 228


 69.2000 USD




 CFD


 SHORT


 46


 69.4100 USD




 CFD


 SHORT


 2,646


 70.9077 USD




 CFD


 SHORT


 2,100


 71.0600 USD




 CFD


 SHORT


 747


 71.0600 USD




 CFD


 SHORT


 700


 71.3714 USD




 CFD


 SHORT


 200


 71.6550 USD




 CFD


 SHORT


 2,165


 73.9152 USD




 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 




 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 




 
(ii) Exercising
 




 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  




 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 




Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 




 
 




 Date of disclosure


20 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEURSRRRRUOUAR